Centene Corp. buy stratec
Start price
28.04.20
/
50%
€63.00
Target price
04.11.21
€75.00
Performance (%)
2.38%
End price
05.11.21
€64.50
Summary
This prediction ended on 05.11.21 with a price of €64.50. With a performance of 2.38%, the BUY prediction by stratec for Centene Corp. closed with a slight gain. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Centene Corp. | 7.404% | 7.404% | -34.076% | -46.416% |
| iShares Core DAX® | 1.432% | 2.628% | 12.457% | 60.347% |
| iShares Nasdaq 100 | 1.892% | -0.458% | 1.248% | 85.806% |
| iShares Nikkei 225® | -1.619% | 11.097% | 27.382% | 64.398% |
| iShares S&P 500 | 1.921% | 1.159% | 1.635% | 59.419% |
Comments by stratec for this prediction
In the thread Centene Corp. diskutieren
Centene Corporation - A Growth Company Perfect For A Value Investor
CNC is growing at a rapid rate and only has a Forward P/E of 10.88. The potential investment in the company is for a growth and value investor.
Revenues: $26,025M (+41.1%); Medicaid: $17,041M (+35.2%); Commercial: $4,119M (+13.0%); Medicare: $3,016M (+118.2%); Medicare PDP: $600M; Other: $1,249M (+54.4%).
Revenues: $26,025M (+41.1%); Medicaid: $17,041M (+35.2%); Commercial: $4,119M (+13.0%); Medicare: $3,016M (+118.2%); Medicare PDP: $600M; Other: $1,249M (+54.4%).
In the thread Trading Centene Corp.
Die von stratec gewählte maximale Laufzeit wurde überschritten